KR20080046602A - 실로스타졸과 은행잎 추출물을 함유한 약제 조성물 - Google Patents
실로스타졸과 은행잎 추출물을 함유한 약제 조성물 Download PDFInfo
- Publication number
- KR20080046602A KR20080046602A KR1020070119484A KR20070119484A KR20080046602A KR 20080046602 A KR20080046602 A KR 20080046602A KR 1020070119484 A KR1020070119484 A KR 1020070119484A KR 20070119484 A KR20070119484 A KR 20070119484A KR 20080046602 A KR20080046602 A KR 20080046602A
- Authority
- KR
- South Korea
- Prior art keywords
- cilostazol
- ginkgo biloba
- biloba extract
- extract
- administration
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (6)
- 실로스타졸(cilostazol)과 은행잎 추출물을 유효성분으로 함유하는 것을 특징으로 하는 항혈전성 약제 조성물.
- 제 1 항에 있어서, 상기 은행잎 추출물은 실로스타졸 100 중량부에 대하여 10 ~ 480 중량부를 함유하고 있는 것을 특징으로 하는 조성물.
- 제 1 항에 있어서, 상기 약제 조성물은 정제, 발포정, 과립제 및 캅셀제로 단일투여 제형화되는 것을 특징으로 하는 조성물.
- 제 3 항에 있어서, 상기 단위투여 제형내의 실로스타졸 함량은 50 ~100 mg, 은행잎 추출물의 함량은 40 ~ 80 mg을 포함하는 것을 특징으로 하는 조성물.
- 실로스타졸과 은행잎 추출물을 유효성분으로 함유하는 것을 특징으로 하는 혈전에 의해 유도되는 질환 예방 및 치료용 항혈전제.
- 제 5 항에 있어서, 상기 혈전에 의해 유도되는 질환은 허혈성 뇌혈관장해, 관상동맥질환, 만성동맥폐색증, 혈관 수술과 뇌지망막출혈 수술 후의 혈전 또는 색전인 것을 특징으로 하는 항혈전제.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/KR2007/005923 WO2008063025A1 (en) | 2006-11-22 | 2007-11-22 | Combination drug of cilostazol and ginkgo biloba extracts |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20060115917 | 2006-11-22 | ||
KR1020060115917 | 2006-11-22 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020100026898A Division KR20100040281A (ko) | 2006-11-22 | 2010-03-25 | 실로스타졸과 은행잎 추출물을 함유한 약제 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20080046602A true KR20080046602A (ko) | 2008-05-27 |
KR100963268B1 KR100963268B1 (ko) | 2010-06-11 |
Family
ID=39663467
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020070119484A KR100963268B1 (ko) | 2006-11-22 | 2007-11-22 | 실로스타졸과 은행잎 추출물을 함유한 약제 조성물 |
KR1020100026898A KR20100040281A (ko) | 2006-11-22 | 2010-03-25 | 실로스타졸과 은행잎 추출물을 함유한 약제 조성물 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020100026898A KR20100040281A (ko) | 2006-11-22 | 2010-03-25 | 실로스타졸과 은행잎 추출물을 함유한 약제 조성물 |
Country Status (1)
Country | Link |
---|---|
KR (2) | KR100963268B1 (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101476349B1 (ko) * | 2012-03-30 | 2014-12-24 | 에스케이케미칼주식회사 | 실로스타졸 및 은행잎 추출물을 유효성분으로 포함하는 난청 예방 또는 치료용 약학적 조성물 |
KR102539234B1 (ko) | 2016-04-07 | 2023-06-02 | 에스케이케미칼 주식회사 | 은행잎 추출물을 포함하는 경구용 서방 제제 |
KR102539236B1 (ko) | 2016-04-07 | 2023-06-02 | 에스케이케미칼 주식회사 | 은행잎 추출물을 포함하는 경구용 서방 제제 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1824463A1 (en) | 2004-12-14 | 2007-08-29 | Menarini Ricerche S.p.A. | Pharmaceutical compositions for the treatment of cellulite |
-
2007
- 2007-11-22 KR KR1020070119484A patent/KR100963268B1/ko active IP Right Review Request
-
2010
- 2010-03-25 KR KR1020100026898A patent/KR20100040281A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20100040281A (ko) | 2010-04-19 |
KR100963268B1 (ko) | 2010-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3388117B2 (ja) | カイガンショウ抽出物に基づく血小板反応性調節剤の調製方法 | |
KR100903030B1 (ko) | 멜리사엽 추출물 분획 및 이를 포함하는 조성물 | |
TW201031651A (en) | Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy | |
TW201022237A (en) | Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved safety profile over conventional warfarin therapy | |
CA3005909A1 (en) | Compositions and methods for treating ischemic stroke | |
EP2862575A1 (en) | Application of piceatannol-3'-o-b-d-glucopyranoside in preparation of medicaments for improving microcirculation block | |
KR100963268B1 (ko) | 실로스타졸과 은행잎 추출물을 함유한 약제 조성물 | |
KR20110082563A (ko) | 통상의 와파린 요법에 비해 효능이 향상된 다비가트란 에텍실레이트 또는 이의 염을 사용하여 혈전증을 치료하거나 예방하는 방법 | |
WO2008063025A1 (en) | Combination drug of cilostazol and ginkgo biloba extracts | |
AU2016322956A1 (en) | Composition and methods thereof | |
Rocca et al. | Effects of the Tibetan herbal preparation Padma 28 on blood lipids and lipid oxidisability in subjects with mild hypercholesterolaemia | |
CA2512149C (en) | Film coated tablet comprising an extract of red vine leaves | |
JP4708744B2 (ja) | 血小板凝集抑制組成物 | |
JP7435442B2 (ja) | 血管内皮機能改善用又は末梢血管の血流改善用組成物 | |
KR20100048628A (ko) | 아스피린 및 은행잎 추출물을 포함하는 약학 조성물 | |
TWI451866B (zh) | 治療及預防患者因心肌缺血所引起的不適的醫藥組合物 | |
KR20150014410A (ko) | 페놀 화합물을 유효성분으로 포함하는 항혈전용 조성물 | |
KR101632448B1 (ko) | 카르보스티릴 및 카르니틴의 조합물 | |
Lee et al. | Antiplatelet and antithrombotic activities of Lindera obtusiloba extract in vitro and in vivo | |
JP4528490B2 (ja) | ギンコライド−aを含有する抗不安剤 | |
WO2017084631A1 (zh) | 预防或治疗脂肪胰、改善脂肪胰引起的胰病变、糖尿病或其他相关病症之组合物及方法 | |
CN102846711B (zh) | 参桂胶囊在制备抗血栓药物中的应用 | |
KR100672950B1 (ko) | 허혈성 심질환 예방 또는 치료용 석창포 추출물 및 이를함유하는 약학적 조성물과 건강 식품 | |
CN106913565B (zh) | 甘草宁m在制备治疗和/或预防血栓性疾病的药物中的应用 | |
JPH01305033A (ja) | 循環改善剤及び循環改善機能性食品並びにし好品 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
AMND | Amendment | ||
AMND | Amendment | ||
A302 | Request for accelerated examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
A107 | Divisional application of patent | ||
AMND | Amendment | ||
J201 | Request for trial against refusal decision | ||
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
J204 | Request for invalidation trial [patent] | ||
J204 | Request for invalidation trial [patent] | ||
J204 | Request for invalidation trial [patent] | ||
J301 | Trial decision |
Free format text: TRIAL DECISION FOR INVALIDATION REQUESTED 20101217 Effective date: 20120109 Free format text: TRIAL DECISION FOR INVALIDATION REQUESTED 20110831 Effective date: 20120109 |
|
J2X1 | Appeal (before the patent court) |
Free format text: INVALIDATION |
|
J121 | Written withdrawal of request for trial | ||
J204 | Request for invalidation trial [patent] | ||
J206 | Request for trial to confirm the scope of a patent right | ||
J301 | Trial decision |
Free format text: TRIAL DECISION FOR INVALIDATION REQUESTED 20120322 Effective date: 20121221 Free format text: TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20120322 Effective date: 20121221 |
|
J302 | Written judgement (patent court) |
Free format text: JUDGMENT (PATENT COURT) FOR INVALIDATION REQUESTED 20120207 Effective date: 20121129 |
|
J2X2 | Appeal (before the supreme court) |
Free format text: APPEAL BEFORE THE SUPREME COURT FOR INVALIDATION |
|
J2X1 | Appeal (before the patent court) |
Free format text: CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE Free format text: INVALIDATION |
|
J221 | Remand (intellectual property tribunal) |
Free format text: REMAND (INTELLECTUAL PROPERTY TRIBUNAL) FOR INVALIDATION |
|
J303 | Written judgement (supreme court) |
Free format text: JUDGMENT (SUPREME COURT) FOR INVALIDATION REQUESTED 20130103 Effective date: 20140213 |
|
J301 | Trial decision |
Free format text: TRIAL DECISION FOR INVALIDATION REQUESTED 20140224 Effective date: 20140313 |
|
FPAY | Annual fee payment |
Payment date: 20140521 Year of fee payment: 5 |
|
J122 | Written withdrawal of action (patent court) |